Allergy Immunology Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allergy immunology program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allergy Immunology Program Today - Breaking & Trending Today

AAAAI Installs New President, Dr. Giselle Mosnaim, at 2021 Virtual Annual Meeting


AAAAI Installs New President, Dr. Giselle Mosnaim, at 2021 Virtual Annual Meeting
PRWeb
FacebookTwitterEmail
MILWAUKEE (PRWEB) March 02, 2021
The American Academy of Allergy, Asthma & Immunology (AAAAI) is pleased to introduce its 2021-2022 President, Giselle S. Mosnaim, MD, MS, FAAAAI.
She was installed as AAAAI President yesterday evening during the Business Meeting that took place on the final day of the 2021 AAAAI Annual Meeting. “While I wish we could have met in person, the COVID-19 pandemic caused us to shift gears to a virtual meeting format, and it was a great success,” said Dr. Mosnaim. The AAAAI is the largest professional membership organization for allergist/immunologists, other medical specialists, allied health and related healthcare professionals all with a special interest in the research and treatment of allergic and immunologic diseases, including asthma. ....

United States , Rush University Medical Center , University Of Illinois At Chicago , Giselle Mosnaim , Giselles Mosnaim , Illinois Society Of Allergy , Massachusetts Institute Of Technology , University Of Chicago Pritzker School Medicine , Allergy Immunology Program , Training Committee , American Academy Of Allergy , Allergist Immunologist Assembly , Health Outcomes , Northshore University Healthsystem , Outcomes Research Institute , Blood Institute , National Heart , New President , Clinical Assistant Professor , Chicago Pritzker School , American Academy , Business Meeting , Massachusetts Institute , Chicago College , Rush University Medical , Lutheran General Hospital ,

Ukko Secures $40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and Sensitivities


Ukko Secures $40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and Sensitivities
Top industry leaders and venture firms unite behind Ukko s efforts to eliminate the world s most prevalent food allergies and sensitivities, including peanuts and gluten
News provided by
Share this article
Share this article
PALO ALTO, Calif., TEL AVIV, Israel and LEVERKUSEN, Germany, Jan. 27, 2021 /PRNewswire/ Ukko, a biotech company with the mission to eliminate food allergies and sensitivities, today announced $40 million in new Series B funding. Ukko harnesses artificial intelligence (AI) and protein engineering to develop healthier food and therapies for food allergies. The new funding will allow Ukko to enter clinical trials with its investigational therapeutic for peanut allergy. It will also accelerate development of Ukko s gluten that is designed for people with celiac and other gluten sensitivities. The round was led by Leaps by Bayer – ....

United States , North Carolina , Raanan Shamir , Kari Nadeau , Bernhard Van Lengerich , Wesleya Burks , Mollie Starr , Alexander Hennig , Carly Scaduto , Edwin Kim , Yanay Ofran , Juergen Eckhardt , Lynda Schneider , Prnewswire Ukko , Annm Veneman , Marc Benioff , Bayer Ag , School Of Medicine , Continental Grain Company , Professor Of Pediatrics At Harvard Medical School , Drug Administration , Allergy Immunology Program , Columbia University , Liver Diseases At Schneider Children Medical Center , Asthma Research At Stanford University , Food Allergy Initiative ,